Especially to A*02/MLANAELA, derived from the melanoma antigen recognized by T cells 1 (known as MART1 or MLANA) in patients #2 and #6, which showed specific TCRs in blood, oWAT, but especially in sWAT, occupying 21.1% and 10.7% of the sequenced sWAT repertoire, respectively. The gene discussed is MLANA; the disease is melanoma.